Molecule Information
General Information of the Molecule (ID: Mol00888)
Name |
D-glucan-1,3-beta--UDP glucosyltransferase (FKS1)
,Saccharomyces cerevisiae
|
||||
---|---|---|---|---|---|
Synonyms |
1;3-beta-D-glucan-UDP glucosyltransferase; Calcineurin dependent protein 1; Calcofluor white hypersensitivity protein 53; Echinocandin target gene protein 1; FK506 sensitivity protein 1; Glucan synthase of cerevisiae protein 1; Papulacandin B resistance protein 1; CND1; CWH53; ETG1; GLS1; GSC1; PBR1; YLR342W; L8300.6
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
FKS1
|
||||
Gene ID | |||||
Sequence |
MNTDQQPYQGQTDYTQGPGNGQSQEQDYDQYGQPLYPSQADGYYDPNVAAGTEADMYGQQ
PPNESYDQDYTNGEYYGQPPNMAAQDGENFSDFSSYGPPGTPGYDSYGGQYTASQMSYGE PNSSGTSTPIYGNYDPNAIAMALPNEPYPAWTADSQSPVSIEQIEDIFIDLTNRLGFQRD SMRNMFDHFMVLLDSRSSRMSPDQALLSLHADYIGGDTANYKKWYFAAQLDMDDEIGFRN MSLGKLSRKARKAKKKNKKAMEEANPEDTEETLNKIEGDNSLEAADFRWKAKMNQLSPLE RVRHIALYLLCWGEANQVRFTAECLCFIYKCALDYLDSPLCQQRQEPMPEGDFLNRVITP IYHFIRNQVYEIVDGRFVKRERDHNKIVGYDDLNQLFWYPEGIAKIVLEDGTKLIELPLE ERYLRLGDVVWDDVFFKTYKETRTWLHLVTNFNRIWVMHISIFWMYFAYNSPTFYTHNYQ QLVDNQPLAAYKWASCALGGTVASLIQIVATLCEWSFVPRKWAGAQHLSRRFWFLCIIFG INLGPIIFVFAYDKDTVYSTAAHVVAAVMFFVAVATIIFFSIMPLGGLFTSYMKKSTRRY VASQTFTAAFAPLHGLDRWMSYLVWVTVFAAKYSESYYFLVLSLRDPIRILSTTAMRCTG EYWWGAVLCKVQPKIVLGLVIATDFILFFLDTYLWYIIVNTIFSVGKSFYLGISILTPWR NIFTRLPKRIYSKILATTDMEIKYKPKVLISQVWNAIIISMYREHLLAIDHVQKLLYHQV PSEIEGKRTLRAPTFFVSQDDNNFETEFFPRDSEAERRISFFAQSLSTPIPEPLPVDNMP TFTVLTPHYAERILLSLREIIREDDQFSRVTLLEYLKQLHPVEWECFVKDTKILAEETAA YEGNENEAEKEDALKSQIDDLPFYCIGFKSAAPEYTLRTRIWASLRSQTLYRTISGFMNY SRAIKLLYRVENPEIVQMFGGNAEGLERELEKMARRKFKFLVSMQRLAKFKPHELENAEF LLRAYPDLQIAYLDEEPPLTEGEEPRIYSALIDGHCEILDNGRRRPKFRVQLSGNPILGD GKSDNQNHALIFYRGEYIQLIDANQDNYLEECLKIRSVLAEFEELNVEQVNPYAPGLRYE EQTTNHPVAIVGAREYIFSENSGVLGDVAAGKEQTFGTLFARTLSQIGGKLHYGHPDFIN ATFMTTRGGVSKAQKGLHLNEDIYAGMNAMLRGGRIKHCEYYQCGKGRDLGFGTILNFTT KIGAGMGEQMLSREYYYLGTQLPVDRFLTFYYAHPGFHLNNLFIQLSLQMFMLTLVNLSS LAHESIMCIYDRNKPKTDVLVPIGCYNFQPAVDWVRRYTLSIFIVFWIAFVPIVVQELIE RGLWKATQRFFCHLLSLSPMFEVFAGQIYSSALLSDLAIGGARYISTGRGFATSRIPFSI LYSRFAGSAIYMGARSMLMLLFGTVAHWQAPLLWFWASLSSLIFAPFVFNPHQFAWEDFF LDYRDYIRWLSRGNNQYHRNSWIGYVRMSRARITGFKRKLVGDESEKAAGDASRAHRTNL IMAEIIPCAIYAAGCFIAFTFINAQTGVKTTDDDRVNSVLRIIICTLAPIAVNLGVLFFC MGMSCCSGPLFGMCCKKTGSVMAGIAHGVAVIVHIAFFIVMWVLESFNFVRMLIGVVTCI QCQRLIFHCMTALMLTREFKNDHANTAFWTGKWYGKGMGYMAWTQPSRELTAKVIELSEF AADFVLGHVILICQLPLIIIPKIDKFHSIMLFWLKPSRQIRPPIYSLKQTRLRKRMVKKY CSLYFLVLAIFAGCIIGPAVASAKIHKHIGDSLDGVVHNLFQPINTTNNDTGSQMSTYQS HYYTHTPSLKTWSTIK Click to Show/Hide
|
||||
Function |
Alternate catalytic subunit of the 1,3-beta-glucan synthase (GS). Synthesizes 1,3-beta-glucan, a major structural component of the yeast cell wall. Involved in cell wall synthesis, maintenance and cell wall remodeling.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Caspofungin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Saccharomyces cerevisiae infection | [1] | |||
Resistant Disease | Saccharomyces cerevisiae infection [ICD-11: 1F29-1F2F] | |||
Resistant Drug | Caspofungin | |||
Molecule Alteration | Missense mutation | p.F639I |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Saccharomyces cerevisiae strain | 4932 | ||
Experiment for Molecule Alteration |
Site-directed mutagenesis; MLST assay | |||
Experiment for Drug Resistance |
Liquid broth microdilution assay | |||
Mechanism Description | One group of amino acid substitutions, in the Fks proteins of S. cerevisiae (F639I, V641k, D646Y) and C. albicans (S645F, S645P, S645Y), maps to a short conserved region of ScFks1p and CaFks1p, which lead to caspofungin resistance in the S. cerevisiae and C. albicans as well as C.krusei. | |||
Disease Class: Saccharomyces cerevisiae infection | [1] | |||
Resistant Disease | Saccharomyces cerevisiae infection [ICD-11: 1F29-1F2F] | |||
Resistant Drug | Caspofungin | |||
Molecule Alteration | Missense mutation | p.V641K |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Saccharomyces cerevisiae strain | 4932 | ||
Experiment for Molecule Alteration |
Site-directed mutagenesis; MLST assay | |||
Experiment for Drug Resistance |
Liquid broth microdilution assay | |||
Mechanism Description | One group of amino acid substitutions, in the Fks proteins of S. cerevisiae (F639I, V641k, D646Y) and C. albicans (S645F, S645P, S645Y), maps to a short conserved region of ScFks1p and CaFks1p, which lead to caspofungin resistance in the S. cerevisiae and C. albicans as well as C.krusei. | |||
Disease Class: Saccharomyces cerevisiae infection | [1] | |||
Resistant Disease | Saccharomyces cerevisiae infection [ICD-11: 1F29-1F2F] | |||
Resistant Drug | Caspofungin | |||
Molecule Alteration | Missense mutation | p.D646Y |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Saccharomyces cerevisiae strain | 4932 | ||
Experiment for Molecule Alteration |
Site-directed mutagenesis; MLST assay | |||
Experiment for Drug Resistance |
Liquid broth microdilution assay | |||
Mechanism Description | One group of amino acid substitutions, in the Fks proteins of S. cerevisiae (F639I, V641k, D646Y) and C. albicans (S645F, S645P, S645Y), maps to a short conserved region of ScFks1p and CaFks1p, which lead to caspofungin resistance in the S. cerevisiae and C. albicans as well as C.krusei. |
Discontinued Drug(s)
1 drug(s) in total
Arborcandin C
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Saccharomyces cerevisiae infection | [2] | |||
Resistant Disease | Saccharomyces cerevisiae infection [ICD-11: 1F29-1F2F] | |||
Resistant Drug | Arborcandin C | |||
Molecule Alteration | Missense mutation | p.N470K |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Saccharomyces cerevisiae strain | 4932 | ||
Experiment for Molecule Alteration |
DNA sequencing assay | |||
Experiment for Drug Resistance |
Broth macrodilution assay | |||
Mechanism Description | FkS1 mutations responsible for selective resistance of Saccharomyces cerevisiae to the novel 1,3-beta-glucan synthase inhibitor arborcandin C. | |||
Disease Class: Saccharomyces cerevisiae infection | [2] | |||
Resistant Disease | Saccharomyces cerevisiae infection [ICD-11: 1F29-1F2F] | |||
Resistant Drug | Arborcandin C | |||
Molecule Alteration | Missense mutation | p.L642S |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Saccharomyces cerevisiae strain | 4932 | ||
Experiment for Molecule Alteration |
DNA sequencing assay | |||
Experiment for Drug Resistance |
Broth macrodilution assay | |||
Mechanism Description | FkS1 mutations responsible for selective resistance of Saccharomyces cerevisiae to the novel 1,3-beta-glucan synthase inhibitor arborcandin C. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.